Synthesis and properties of new derivatives of 3-benzylspiro[benzo[h]quinazoline-5,1'-cycloheptane]-4(6H)-one

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Condensation of 3-benzyl-2-thioxo-2,3-dihydro-1H-spiro[benzo[h]quinazoline-5,1'-cycloheptane]-4(6H)-one with 5,5-dialkyl-2-chloromethylbenzo[h]quinazolines were used to synthesize dibenzo[h]quinazoline compounds in which spiro[benzo[h]quinazoline-5,1'-cycloheptane] in the second position is linked via a -SCH2- linker to another benzo[h]quinazoline molecule. The specified 2-thioxobenzo[h]quinazoline, under similar conditions, upon reaction with methylene iodide, forms 2,2'-[(methylenebis(sulfandiyl)]bis{3-benzyl-3H-spiro[benzo[h]quinazoline-5,1'-cycloheptane]}-4(6H)-one. A transition was made from the starting benzo[h]quinazoline to the 2-hydrazinoderivative, which is cleaved in the presence of caustic potash to form 3-benzyl-3H-spiro[benzo[h]quinazoline-5,1'-cycloheptane]-4(6H)-one. Based on the 2-hydrazino derivative, hydrazone, thiosemicarbazide, and 4-benzyl-4H-spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1'-cycloheptanones] have been synthesized. Condensation of 4-benzyl-1-mercapto-4H-spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1'-cycloheptane]-5(7H)-one with alkyl halides 1-sulfanyl-substituted triazolobenzo[h]quinazoline derivatives of various structures were obtained. The antibacterial properties of the synthesized compounds were studied.

作者简介

A. Markosyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of NAS RA

Email: ashot@mаrkosyan.am
prosp. Azatutyun, 26, Yerevan, 0014 Armenia

A. Ayvazyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of NAS RA

prosp. Azatutyun, 26, Yerevan, 0014 Armenia

S. Gabrielyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of NAS RA

prosp. Azatutyun, 26, Yerevan, 0014 Armenia

S. Mamyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of NAS RA

prosp. Azatutyun, 26, Yerevan, 0014 Armenia

R. Muradyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of NAS RA

prosp. Azatutyun, 26, Yerevan, 0014 Armenia

参考

  1. Shafi S.S., Kumar S.S. Intern. J. Chem.Tech. Res. (USA). 2015, 8, 164–169.
  2. Wu L., Zhang Ch. RSC Advances. 2016, 34, 287555–28562. doi: 10.1039/C6RA03323G
  3. Ohtomo H., Tagata T., Sasaki K., Hirota T., Okuda K. Tetrahedron. 2007, 63, 12541–12546. doi: 10.1016/j.tet.2007.10.024
  4. Keshari A.K., Singh A.K., Raj V., Rai A., Trivedi P., Ghosh B., Kumar U., Rawat A., Kumar D., Saha S. Drug Des. Devel. Ther. 2017, 11, 1623–1642. doi: 10.2147/DDDT.S136692
  5. Kantin G.P., Krasavin M. Chem. Heterocycl. Compd. 2016, 52, 918–922. doi: 10.1007/s10593-017-1985-0
  6. Kamela M.M., Zagharyb W.A., Al-Wablic R.I., Anwa- ra M.M. Egyptian Pharm. J. 2016, 15, 98–131. doi: 10.4103/1687-4315.197580
  7. Pozharskii A.F., Ozeryanskii V.A., Mikshiev V.Y., Antonov A.S., Chernyshev A.V., Metelitsa A.V., Borod- kin G.S., Fedik N.S., Dyablo O.V. J. Org. Chem. 2016, 81, 5574–5587. doi: 10.1021/acs.joc.6b00917
  8. Mikshiev V.Y., Antonov A.S., Pozharskii A.F. Org. Lett. 2016, 18, 2872–2875. doi: 10.1021/acs.joc.6b00917
  9. Sahoo M.,Jena L., Daf S., Kumar S. Genomics Inform. 2016, 14, 104–111. doi: 10.5808/GI.2016.14.3.104
  10. Gali R., Banothu J., Porika M., Velpula R., Hnamte S., Bavantula R., Abbagani S., Busi S. Bioorg. Med. Chem. Lett. 2014, 24, 4239–4242.
  11. Malinowski Z., Fornal E., Warpas A., Nowak M. Monatsh. Chem. 2018, 9, 1999–2011. doi: 10.1007/s00706-018-2268-x
  12. Ebied M.Y., Zaghary W.A., Amin K.M., Hammad Sh.F. J. Adv. Pharm. Res. 2017, 1, 216–227. doi: 10.21608/aprh.2017.4043
  13. Maurya H.K., Hasanain M., Singh S., Sarkar J., Du- bey V., Shukla A., Luqman S., Khanc F., Gupta A. RSC Advances. 2016, 22, 18607–18618.
  14. Gupta R., Chaudhary R.P. Phosphorus, Sulfur, Silicon Relat. Elem. 2012, 187, 735–742.
  15. Gomha S.M., Abbas E.M.H., Farghaly T.A. J. Het. Chem. 2017, 54, 610–617. doi: 10.1002/jhet.2632
  16. Маркосян А.И., Айвазян А.С., Габриелян С.А., Мамян С.С., Арсенян Ф.Г., Сафарян А.Г., Араке- лян А.С. Хим.-фарм. ж. 2021, 55, 24–28. [Marko- syan A.I., Ayvazyan A.S., Gabrielyan S.A., Mamyan S.S., Arsenyan F.H., Safaryan A.H, Arakelyan H.S. Pharm.-chem. j. 2021, 55, 133–137.] doi 0.30906/0023-1134-2021-55-2-24-28
  17. Маркосян А.И., Айрапетян К.К., Габриелян С.А., Ширинян В.З., Мамян С.С., Авакимян Дж.А., Степанян Г.М. ЖОрХ. 2018, 54, 604–611. [Marko- syan A.I., Hayrapetyan K.K., Gabrielyan S.H., Shirinyan V.Z., Mamyan S. S., Avakimyan J.A., Stepa- nyan G.M. Russ. J. Org. Chem. 2018, 54, 606–613.] doi: 10.1134/S1070428018040152
  18. Маркосян А.И., Диланян С.В., Сукасян Р.С., Арсенян Ф.Г., Гарибджанян Б.Т. Хим.-фарм. ж. 2008, 42, 16–19. [Markosyan A.I., Dilanyan S.V., Suka- syan R.S., Arsenyan F.G., Garibdzhanyan B.T. Pharm.-chem. j. 2008, 42, 118–121.] doi: 10.30906/0023-1134-2008-42-3-16-19
  19. Markosyan A.I., Ayvazyan A.S., Gabrielyan S.H., Mamyan S.S. Chem. J. Armenia. 2019, 72, 469–482.
  20. Маркосян А.И., Айвазян А.С., ЖОрХ. 2021, 57, 410–419. doi: 10.31857/S0514749221030095
  21. Руководство по проведению доклинических исследований лекарственных средств, Ред. А.Н. Миронов, М: Медицина, 2012, 509–524.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russian Academy of Sciences, 2025